There are 805 resources available
YO28 - TKI for Metastatic Non Small Cell Lung Cancer in Pregnancy.
Presenter: Siti Mariam Yacob
Session: Young Oncologists clinical cases discussion
Resources:
Abstract
YO29 - Multiple primary cancers (MPC) of breast and lung with primary EGFR T790M mutation Responded to Aumolertinib: A case report
Presenter: Shengnan Kong
Session: Young Oncologists clinical cases discussion
Resources:
Abstract
482MO - Clinical usefulness of next-generation sequencing for metastatic or unresectable gastric cancer in molecular profiling-guided therapy era
Presenter: Songji Choi
Session: Mixed session - Proffered Paper and Mini Oral: Developmental and precision medicine
Resources:
Abstract
483MO - RNA-based multiplex polymerase chain reaction and sequencing to detect fusion genes in melanoma
Presenter: Tokimasa Hida
Session: Mixed session - Proffered Paper and Mini Oral: Developmental and precision medicine
Resources:
Abstract
YO1 - Trastuzumab deruxtecan and Stereotactic radiosurgery (SRS) in HER2-positive (HER2+) breast cancer with brain metastases (BM)
Presenter: Teng Meng
Session: Young Oncologists clinical cases discussion
Resources:
Abstract
YO2 - Taking Control With The Knife: Managing Brain Metastasis With Gamma Knife In Metastatic Breast Cancer in Pregnancy
Presenter: Tan Keh Yee
Session: Young Oncologists clinical cases discussion
Resources:
Abstract
LBA2 - Belzutifan versus everolimus for previously treated advanced clear cell renal cell carcinoma (ccRCC): Updated follow-up of the East Asian subgroup of the randomized phase III LITESPARK-005 trial
Presenter: Jae-Lyun Lee
Session: Proffered Paper session: Genitourinary tumours
Resources:
Abstract
128MO - Final overall survival for the phase III, KEYNOTE-811 study of pembrolizumab plus trastuzumab and chemotherapy for HER2+ advanced, unresectable or metastatic G/GEJ adenocarcinoma
Presenter: Sun Young Rha
Session: Mini Oral session: Gastrointestinal tumours
Resources:
Abstract
402O - Preliminary results of phase II study to evaluate safety and efficacy of combination pucotenlimab with epidermal growth factor receptor-ADC (EGFR-ADC) MRG003 in recurrent or metastatic nasopharyngeal carcinoma (R/M-NPC)
Presenter: Danyun Ruan
Session: Proffered Paper session: Head and neck cancers
Resources:
Abstract
268O - Determinants of neoadjuvant immune checkpoint inhibitor plus tyrosine kinase inhibitor therapy response in renal cell carcinoma
Presenter: Liangyou Gu
Session: Proffered Paper session: Genitourinary tumours
Resources:
Abstract